Tamoxifen News and Research

RSS
Tamoxifen is a drug used to treat certain types of breast cancer in women and men. It is also used to prevent breast cancer in women who have had ductal carcinoma in situ (abnormal cells in the ducts of the breast) and in women who are at a high risk of developing breast cancer. Tamoxifen is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in the breast. Tamoxifen is a type of antiestrogen. Also called tamoxifen citrate.
SLU researchers aim to tackle diabetes and obesity by capturing benefits of exercise in pill form

SLU researchers aim to tackle diabetes and obesity by capturing benefits of exercise in pill form

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

Shorter radiation treatment for breast cancer patients could reduce health care spending

Shorter radiation treatment for breast cancer patients could reduce health care spending

Isoflavone consumption linked to decrease in mortality for some breast cancer patients

Isoflavone consumption linked to decrease in mortality for some breast cancer patients

Dietary soy products could be safe, beneficial for women diagnosed with breast cancer

Dietary soy products could be safe, beneficial for women diagnosed with breast cancer

Study finds under and misuse of adjuvant endocrine therapy for breast cancer patients

Study finds under and misuse of adjuvant endocrine therapy for breast cancer patients

Researchers reveal how soy consumption impacts common breast cancer treatment

Researchers reveal how soy consumption impacts common breast cancer treatment

Delays in availability of new treatments and incomprehensible price rises disadvantage cancer patients

Delays in availability of new treatments and incomprehensible price rises disadvantage cancer patients

TSRI researchers develop new approach to find how environmental estrogens impact public health

TSRI researchers develop new approach to find how environmental estrogens impact public health

TSRI scientists develop new approach for understanding diverse effects of endocrine-disruptors

TSRI scientists develop new approach for understanding diverse effects of endocrine-disruptors

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Aromatase inhibitors show advantages over tamoxifen in early-stage breast cancer

Research findings could offer novel approach for cancer prevention in women with BRCA1 mutations

Research findings could offer novel approach for cancer prevention in women with BRCA1 mutations

Multifunctional RNA nanoparticles could overcome treatment resistance in breast cancer, study shows

Multifunctional RNA nanoparticles could overcome treatment resistance in breast cancer, study shows

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Controversial hormone could fight against recurring breast cancers

Controversial hormone could fight against recurring breast cancers

Kratom may be safer and less addictive than current treatments for pain, research suggests

Kratom may be safer and less addictive than current treatments for pain, research suggests

Electro-acupuncture may be effective in treating sleep disturbances in women with breast cancer

Electro-acupuncture may be effective in treating sleep disturbances in women with breast cancer

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows

Drug combination therapy delays progression of advanced breast cancer without side effects, study shows